MENU
FEB 05, 2020 8:00 AM PST

Emerging Issues in the Coagulation Laboratory

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • QA Manager for Specialty Testing Supervisor, Special Coagulation and Hematology, New York Presbyterian Hospital
    Biography
      Donna is Quality Assurance (QA) Manager, Specialty Testing Supervisor, Special Coagulation and Special Hematology at New York Presbyterian Hospital- Columbia in New York City. She has 34 years clinical laboratory experience, 6 years industry clinical trial experience, including PhD work on Standardization of Laboratory Testing (all but dissertation). Donna has written several book chapters, many publications and presented many coagulation lectures to diverse audiences at all levels of expertise. She is adjunct professor at York College and Rutgers University. Donna presently serves on the Executive Committee of the North American Specialized Coagulation Laboratory Association (NASCOLA) as a Secretary, Publication Committee and Pre-Curriculum Committee for the American Society for Clinical Pathology (ASCP), and the Expert Committee for Hematology for the Clinical Laboratory Standards Institute (CLSI). She is also a member of International Society on Thrombosis and Haemostasis (ISTH), International Society for Laboratory Hematology (ISLH) and ASCP.

    Abstract

    The compendium of newly emerging and currently available hemophilia and anticoagulant treatments, while offering new choices for improved patient care, can create significant levels of interference with routine and specialized laboratory coagulation assays. Our new educational session will examine the interference in coagulation tests from presence of the direct oral anticoagulants (DOACs) and the extended half-life (EHL) and non-factor products. It is important for laboratories to be aware of how both classes of these products, when present, can impact downstream results and clinical decision making.  

    Upon completion of this session, participants will be able to:
    1. Identify how to detect DOAC’s with routine coagulation tests and how they impact results.
    2. Understand how the new EHL products for hemophilia A and B perform in relation to the laboratory’s coagulation reagents.
    3. Increase awareness of the impact of these issues on coagulation testing.

     

     

    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.  CE credits are available for this webinar up to 2 years from the date of the live broadcast


    Show Resources
    Show Resources
    Attendees
    • See more